234 related articles for article (PubMed ID: 34380717)
1. Assessing variation among the national essential medicines lists of 21 high-income countries: a cross-sectional study.
Taglione MS; Persaud N
BMJ Open; 2021 Aug; 11(8):e045262. PubMed ID: 34380717
[TBL] [Abstract][Full Text] [Related]
2. Withdrawn medicines included in the essential medicines lists of 136 countries.
Charles O; Onakpoya I; Benipal S; Woods H; Bali A; Aronson JK; Heneghan C; Persaud N
PLoS One; 2019; 14(12):e0225429. PubMed ID: 31791048
[TBL] [Abstract][Full Text] [Related]
3. Comparison of antibiotics included in national essential medicines lists of 138 countries using the WHO Access, Watch, Reserve (AWaRe) classification: a cross-sectional study.
Adekoya I; Maraj D; Steiner L; Yaphe H; Moja L; Magrini N; Cooke G; Loeb M; Persaud N
Lancet Infect Dis; 2021 Oct; 21(10):1429-1440. PubMed ID: 34332706
[TBL] [Abstract][Full Text] [Related]
4. Essential medicines for cancer: WHO recommendations and national priorities.
Robertson J; Barr R; Shulman LN; Forte GB; Magrini N
Bull World Health Organ; 2016 Oct; 94(10):735-742. PubMed ID: 27843163
[TBL] [Abstract][Full Text] [Related]
5. Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability.
Husain MJ; Datta BK; Kostova D; Joseph KT; Asma S; Richter P; Jaffe MG; Kishore SP
J Am Heart Assoc; 2020 May; 9(9):e015302. PubMed ID: 32338557
[TBL] [Abstract][Full Text] [Related]
6. Comparison of essential medicines lists in 137 countries.
Persaud N; Jiang M; Shaikh R; Bali A; Oronsaye E; Woods H; Drozdzal G; Rajakulasingam Y; Maraj D; Wadhawan S; Umali N; Wang R; McCall M; Aronson JK; Plüddemann A; Moja L; Magrini N; Heneghan C
Bull World Health Organ; 2019 Jun; 97(6):394-404C. PubMed ID: 31210677
[TBL] [Abstract][Full Text] [Related]
7. Relation between opioid consumption and inclusion of opioids in 137 national essential medicines lists.
Richards GC; Aronson JK; Heneghan C; Mahtani KR; Koshiaris C; Persaud N
BMJ Glob Health; 2020 Nov; 5(11):. PubMed ID: 33173012
[TBL] [Abstract][Full Text] [Related]
8. Access to cancer medicines deemed essential by oncologists in 82 countries: an international, cross-sectional survey.
Fundytus A; Sengar M; Lombe D; Hopman W; Jalink M; Gyawali B; Trapani D; Roitberg F; De Vries EGE; Moja L; Ilbawi A; Sullivan R; Booth CM
Lancet Oncol; 2021 Oct; 22(10):1367-1377. PubMed ID: 34560006
[TBL] [Abstract][Full Text] [Related]
9. Baseline assessment of WHO's target for both availability and affordability of essential medicines to treat non-communicable diseases.
Ewen M; Zweekhorst M; Regeer B; Laing R
PLoS One; 2017; 12(2):e0171284. PubMed ID: 28170413
[TBL] [Abstract][Full Text] [Related]
10. Essential cancer medicines in the national lists of countries of the WHO South-East Asia Region: a descriptive assessment.
Chivukula MV; Tisocki K
WHO South East Asia J Public Health; 2018 Sep; 7(2):90-98. PubMed ID: 30136667
[TBL] [Abstract][Full Text] [Related]
11. Defining Essential Childhood Cancer Medicines to Inform Prioritization and Access: Results From an International, Cross-Sectional Survey.
Denburg AE; Fundytus A; Khan MS; Howard SC; Antillon-Klussmann F; Sengar M; Lombe D; Hopman W; Jalink M; Gyawali B; Trapani D; Roitberg F; De Vries EGE; Moja L; Ilbawi A; Sullivan R; Booth CM
JCO Glob Oncol; 2022 Jun; 8():e2200034. PubMed ID: 35749676
[TBL] [Abstract][Full Text] [Related]
12. An Analysis of Accessibility of Representative Psychotropic Medicine From the World Health Organization Model List of Essential Medicines in Developing Countries With Different Income Levels.
Shi Y; Zhang L; Fu J; Shao R; Yan J
Value Health; 2023 Apr; 26(4):528-535. PubMed ID: 36442833
[TBL] [Abstract][Full Text] [Related]
13. Access to Cytotoxic Medicines by Children With Cancer: A Focus on Low and Middle Income Countries.
Barr R; Robertson J
Pediatr Blood Cancer; 2016 Feb; 63(2):287-91. PubMed ID: 26375626
[TBL] [Abstract][Full Text] [Related]
14. Essential medicines lists for children of WHO, India, South Africa, and EML of China: A comparative study.
Liu D; Cheng J; Zhang LL; Li YP; Zeng LN; Zhang C; Gui G
J Evid Based Med; 2017 Nov; 10(4):271-280. PubMed ID: 28276634
[TBL] [Abstract][Full Text] [Related]
15. Selection of Blood, Blood Components, and Blood Products as Essential Medicines in 105 Low- and Middle-Income Countries.
Samukange WT; Gardarsdottir H; Leufkens HGM; Mantel-Teeuwisse AK
Transfus Med Rev; 2020 Apr; 34(2):94-100. PubMed ID: 31761652
[TBL] [Abstract][Full Text] [Related]
16. Global status of essential medicine selection: a systematic comparison of national essential medicine lists with recommendations by WHO.
Piggott T; Nowak A; Brignardello-Petersen R; Cooke GS; Huttner B; Schünemann HJ; Persaud N; Magrini N; Moja L
BMJ Open; 2022 Feb; 12(2):e053349. PubMed ID: 35144950
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of essential medicines for cardiovascular diseases in countries of the WHO Eastern Mediterranean Region.
Mehrtash H; Laing R; Wirtz VJ
East Mediterr Health J; 2018 Jul; 24(5):427-434. PubMed ID: 30043961
[TBL] [Abstract][Full Text] [Related]
18. Insights from the WHO and National Lists of Essential Medicines: Focus on Pediatric Diabetes Care in Africa.
Rowlands A; Ameyaw E; Rutagarama F; Dipesalema J; Majaliwa ES; Mbogo J; Ogle GD; Chanoine JP
Horm Res Paediatr; 2018; 90(2):82-92. PubMed ID: 30048982
[TBL] [Abstract][Full Text] [Related]
19. Prices of antihypertensive medicines in sub-Saharan Africa and alignment to WHO's model list of essential medicines.
Twagirumukiza M; Annemans L; Kips JG; Bienvenu E; Van Bortel LM
Trop Med Int Health; 2010 Mar; 15(3):350-61. PubMed ID: 20070634
[TBL] [Abstract][Full Text] [Related]
20. Selection of WHO-recommended essential medicines for non-communicable diseases on National Essential Medicines Lists.
Jarvis JD; Woods H; Bali A; Oronsaye E; Persaud N
PLoS One; 2019; 14(8):e0220781. PubMed ID: 31398195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
